Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PCR-Based Diagnostics Move Out of the Lab and into the Field

By LabMedica International staff writers
Posted on 10 Sep 2014
Researchers in New Zealand have revealed a novel battery-powered, handheld quantitative PCR analyzer for use under field conditions to detect minute levels of viral or bacterial DNA.

Investigators at the University of Otago (New Zealand) recently described a robust unit weighing about the same as a typical laptop computer and able to fit on the palm of the hand. More...
The so-called "Freedom4" instrument boasts a six-hour battery life and can be attached by cable to a laptop computer, or connected wirelessly to a smart phone or tablet computer that is running a custom software application able to analyze and interpret the test results.

“We are immensely proud that we have created this brilliant device; there is currently no other system in the world that compares in terms of the analytical power we have achieved at this level of mobility and ease of use, said Dr. Jo-Ann Stanton, senior research fellow in the department of anatomy at the University of Otago. “This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analyzing samples from various locations, make their diagnoses and treat infected animals—all in one trip.”

A prototype Freedom4 instrument was evaluated by the New Zealand Institute of Environmental and Scientific Research (Wellington). Results obtained by assays for toxin-producing E. coli, and several gastrointestinal and respiratory viruses—including the H1N1 serotype influenza virus—were said to correlate well with those from much larger laboratory-based DNA analysis systems.

Related Links:
University of Otago
New Zealand Institute of Environmental and Scientific Research



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.